PREDNICEN-M Drug Patent Profile
✉ Email this page to a colleague
When do Prednicen-m patents expire, and when can generic versions of Prednicen-m launch?
Prednicen-m is a drug marketed by Schwarz Pharma and is included in one NDA.
The generic ingredient in PREDNICEN-M is prednisone. There are sixteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the prednisone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prednicen-m
A generic version of PREDNICEN-M was approved as prednisone by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREDNICEN-M?
- What are the global sales for PREDNICEN-M?
- What is Average Wholesale Price for PREDNICEN-M?
Summary for PREDNICEN-M
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Patent Applications: | 5,110 |
| DailyMed Link: | PREDNICEN-M at DailyMed |
US Patents and Regulatory Information for PREDNICEN-M
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schwarz Pharma | PREDNICEN-M | prednisone | TABLET;ORAL | 084655-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
